Radiopharm Theranostics Limited (RADX)
Nasdaq: RADX · Pharmaceutical Preparations · filing with the SEC since 2022
Who runs Radiopharm Theranostics Limited
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Canevari Riccardo
Managing Director and CEO. First filing Mar 2026, latest Mar 31, 2026, 0 filings in all.
Officers reporting now
3
of 8 people with a filing in the last fifteen months
Directors reporting now
5
8 people on the record since 2026
Officerssales are open-market, Oct 27, 2025 to Oct 27, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Voliotis Dimitris | Chief Medical Officer | May 2026 | Oct 27, 2026 | none |
| Laurita Aaron James | Chief Financial Officer | Apr 2026 | Apr 30, 2026 | none |
| Canevari Riccardo | Managing Director and CEO | Mar 2026 | Mar 31, 2026 | none |
Directorssales are open-market, Oct 27, 2025 to Oct 27, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Hopper Paul | director | May 2026 | May 6, 2026 | none |
| Donnelly Noel | director | Apr 2026 | Apr 1, 2026 | none |
| Turner Ian Lawrence | director | Apr 2026 | Apr 1, 2026 | none |
| Larkin Hester Denise | director | Mar 2026 | Mar 31, 2026 | none |
| Goodwin Bruce Michael | director | Mar 2026 | Mar 18, 2026 | none |
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.